Milestone Scientific Inc. (NYSE:MLSS – Get Free Report)’s stock price rose 2% during trading on Friday . The stock traded as high as $0.4030 and last traded at $0.3990. 125,254 shares traded hands during trading, a decline of 88% from the average session volume of 1,027,132 shares. The stock had previously closed at $0.3911.
Milestone Scientific Stock Performance
The firm has a market cap of $35.29 million, a price-to-earnings ratio of -5.70 and a beta of 1.05. The business has a fifty day moving average of $0.37 and a two-hundred day moving average of $0.32.
Institutional Trading of Milestone Scientific
An institutional investor recently raised its stake in Milestone Scientific stock. Raymond James Financial Inc. boosted its holdings in Milestone Scientific Inc. (NYSE:MLSS – Free Report) by 416.7% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 62,000 shares of the company’s stock after acquiring an additional 50,000 shares during the period. Raymond James Financial Inc. owned 0.08% of Milestone Scientific worth $39,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 5.79% of the company’s stock.
Milestone Scientific Company Profile
Milestone Scientific, Inc, listed on the New York Stock Exchange under the symbol MLSS, is a medical device company specializing in the development and commercialization of computer-controlled injection technologies for local anesthesia and pain management. The company’s proprietary systems are designed to enhance patient comfort, improve clinical outcomes and streamline the administration of anesthetics in dental and medical procedures. Through its precision delivery platforms, Milestone Scientific aims to set a new standard for minimally invasive injections.
At the core of Milestone Scientific’s product portfolio is the Single Tooth Anesthesia (STA) System, which uses Comunication Controlled Local Anesthetic Delivery (CCLAD) technology to provide targeted, atraumatic anesthesia for individual dental roots.
See Also
- Five stocks we like better than Milestone Scientific
- Netflix’s Big Sell-Off May Be Sending the Wrong Signal
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
